Topic covered include:
1:38 – The typical time frame for process design and process qualification for a biopharmaceutical development program
2:10 – The driving forces for the rapid scale up of production of vaccines and therapies
2:31 – The role that influx of financial investment (government and private) played in advancing process development
3:44 – Technologies that contribute to accelerated process development
6:36 – The role of equipment and material suppliers in expediting process development
9:40 – The industry’s adoption of more rapid process development approaches
10:47 – The future of “manufacturing at risk” in the industry
11:29 – Lessons/insight that the pandemic experience revealed about traditional process development methods that can contribute to improvements for non-pandemic drug development applications
Related Content